Vamil Divan
Stock Analyst at Guggenheim
(4.81)
# 476
Out of 4,501 analysts
975
Total ratings
58.7%
Success rate
14.4%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Reiterated: Buy | $226 → $207 | $118.26 | +75.04% | 16 | Jul 9, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $124 | $83.78 | +48.01% | 20 | Jul 9, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $249 → $261 | $249.91 | +4.44% | 129 | Jul 8, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $56 → $76 | $42.45 | +79.03% | 15 | Jul 8, 2026 | |
| SCYX SCYNEXIS | Maintained: Buy | $5 → $3 | $4.57 | -34.28% | 5 | Jul 1, 2026 | |
| UNCY Unicycive Therapeutics | Maintained: Buy | $37 | $5.26 | +603.42% | 8 | Jun 30, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $266 → $270 | $259.10 | +4.21% | 52 | Jun 26, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $56 → $65 | $58.47 | +11.17% | 28 | Jun 25, 2026 | |
| ABSI Absci | Reiterated: Buy | $15 | $11.47 | +30.78% | 5 | Jun 25, 2026 | |
| MRK Merck & Co. | Maintained: Buy | $140 | $125.07 | +11.94% | 48 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $24.25 | +48.45% | 117 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $47 | $22.48 | +109.07% | 8 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $27.87 | +54.29% | 12 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.29 | +74.88% | 9 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 38.00 | $12.96 | +193.21% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $351 → $340 | $363.62 | -6.50% | 7 | May 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 → $11 | $5.30 | +107.74% | 8 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.13 | +93.70% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $7 | $1.80 | +288.89% | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $12.03 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | $13.84 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.175 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $26 | $6.51 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,216.95 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $100.03 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.62 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 | $248.95 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $6.85 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $26.41 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $53.78 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $10 | $3.12 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $78.62 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $667.95 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $139 | $43.90 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $496.50 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $16.98 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $36.81 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $95 | $180.55 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $28.78 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $33.57 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.36 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.67 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $33.10 | n/a | 55 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $59 → $55 | $57.94 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $30.59 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $98.04 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $16.20 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $29 | $3.19 | n/a | 11 | Mar 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $198.91 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $0.7872 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $6.10 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $193.76 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $134.84 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $133.59 | n/a | 1 | Mar 5, 2013 |
Insmed
Jul 9, 2026
Reiterated: Buy
Price Target: $226 → $207
Current: $118.26
Upside: +75.04%
ANI Pharmaceuticals
Jul 9, 2026
Reiterated: Buy
Price Target: $124
Current: $83.78
Upside: +48.01%
AbbVie
Jul 8, 2026
Reiterated: Buy
Price Target: $249 → $261
Current: $249.91
Upside: +4.44%
Vera Therapeutics
Jul 8, 2026
Reiterated: Buy
Price Target: $56 → $76
Current: $42.45
Upside: +79.03%
SCYNEXIS
Jul 1, 2026
Maintained: Buy
Price Target: $5 → $3
Current: $4.57
Upside: -34.28%
Unicycive Therapeutics
Jun 30, 2026
Maintained: Buy
Price Target: $37
Current: $5.26
Upside: +603.42%
Johnson & Johnson
Jun 26, 2026
Reiterated: Buy
Price Target: $266 → $270
Current: $259.10
Upside: +4.21%
Travere Therapeutics
Jun 25, 2026
Reiterated: Buy
Price Target: $56 → $65
Current: $58.47
Upside: +11.17%
Absci
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $11.47
Upside: +30.78%
Merck & Co.
Jun 2, 2026
Maintained: Buy
Price Target: $140
Current: $125.07
Upside: +11.94%
Jun 1, 2026
Maintained: Buy
Price Target: $36
Current: $24.25
Upside: +48.45%
Jun 1, 2026
Reiterated: Buy
Price Target: $32 → $47
Current: $22.48
Upside: +109.07%
May 28, 2026
Reiterated: Buy
Price Target: $43
Current: $27.87
Upside: +54.29%
May 12, 2026
Reiterated: Buy
Price Target: $11
Current: $6.29
Upside: +74.88%
May 6, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: $12.96
Upside: +193.21%
May 3, 2026
Maintained: Hold
Price Target: $351 → $340
Current: $363.62
Upside: -6.50%
Apr 16, 2026
Maintained: Buy
Price Target: $13 → $11
Current: $5.30
Upside: +107.74%
Mar 20, 2026
Maintained: Buy
Price Target: $8
Current: $4.13
Upside: +93.70%
Jul 13, 2025
Maintained: Buy
Price Target: $6 → $7
Current: $1.80
Upside: +288.89%
May 29, 2025
Maintained: Hold
Price Target: n/a
Current: $12.03
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: $13.84
Upside: n/a
May 6, 2024
Maintained: Hold
Price Target: n/a
Current: $0.175
Upside: n/a
Jun 15, 2023
Maintained: Buy
Price Target: $50 → $26
Current: $6.51
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,216.95
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $100.03
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $8.62
Upside: n/a
Jun 27, 2022
Maintained: Buy
Price Target: $49
Current: $248.95
Upside: n/a
Jun 21, 2022
Maintained: Buy
Price Target: $15
Current: $6.85
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $26.41
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $53.78
Upside: n/a
May 24, 2022
Maintained: Buy
Price Target: $20 → $10
Current: $3.12
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $78.62
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $667.95
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $139
Current: $43.90
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $496.50
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $16.98
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $36.81
Upside: n/a
May 4, 2022
Maintained: Hold
Price Target: $95
Current: $180.55
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $28.78
Upside: n/a
May 7, 2021
Maintained: Buy
Price Target: $37
Current: $33.57
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.36
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $4.67
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $33.10
Upside: n/a
May 29, 2019
Maintained: Hold
Price Target: $59 → $55
Current: $57.94
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $30.59
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $98.04
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $16.20
Upside: n/a
Mar 20, 2017
Upgraded: Hold
Price Target: $29
Current: $3.19
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $198.91
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $0.7872
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $6.10
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $193.76
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $134.84
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $133.59
Upside: n/a